Related references
Note: Only part of the references are listed.Influence of ejection fraction on outcomes and efficacy of spironolactone in patients with heart failure with preserved ejection fraction
Scott D. Solomon et al.
EUROPEAN HEART JOURNAL (2016)
Effect of Caloric Restriction or Aerobic Exercise Training on Peak Oxygen Consumption and Quality of Life in Obese Older Patients With Heart Failure With Preserved Ejection Fraction A Randomized Clinical Trial
Dalane W. Kitzman et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2016)
Effect of Aldosterone Antagonism on Exercise Tolerance in Heart Failure With Preserved Ejection Fraction
Wojciech Kosmala et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2016)
Determinants of exercise intolerance in patients with heart failure and reduced or preserved ejection fraction
Mark J. Haykowsky et al.
JOURNAL OF APPLIED PHYSIOLOGY (2015)
The effect of aldosterone-antagonist therapy on aortic elastic properties in patients with nonischemic dilated cardiomyopathy
Enrico Vizzardi et al.
JOURNAL OF CARDIOVASCULAR MEDICINE (2015)
Mechanisms of Exercise Intolerance in Heart Failure With Preserved Ejection Fraction The Role of Abnormal Peripheral Oxygen Extraction
Bishnu P. Dhakal et al.
CIRCULATION-HEART FAILURE (2015)
Regional Variation in Patients and Outcomes in the Treatment of Preserved Cardiac Function Heart Failure With an Aldosterone Antagonist (TOPCAT) Trial
Marc A. Pfeffer et al.
CIRCULATION (2015)
Causes of Exercise Intolerance in Heart Failure With Preserved Ejection Fraction: Searching for Consensus
Nicholas E. Houstis et al.
JOURNAL OF CARDIAC FAILURE (2014)
Spironolactone for Heart Failure with Preserved Ejection Fraction
Bertram Pitt et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Effect of Spironolactone on Diastolic Function and Exercise Capacity in Patients With Heart Failure With Preserved Ejection Fraction The Aldo-DHF Randomized Controlled Trial
Frank Edelmann et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2013)
Relationship of Flow-Mediated Arterial Dilation and Exercise Capacity in Older Patients With Heart Failure and Preserved Ejection Fraction
Mark J. Haykowsky et al.
JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES (2013)
Reliability of Peak Exercise Testing in Patients With Heart Failure With Preserved Ejection Fraction
Jessica M. Scott et al.
AMERICAN JOURNAL OF CARDIOLOGY (2012)
Prevalence, Clinical Phenotype, and Outcomes Associated With Normal B-Type Natriuretic Peptide Levels in Heart Failure With Preserved Ejection Fraction
Venkatesh Y. Anjan et al.
AMERICAN JOURNAL OF CARDIOLOGY (2012)
Clinical Recommendations for Cardiopulmonary Exercise Testing Data Assessment in Specific Patient Populations
Marco Guazzi et al.
CIRCULATION (2012)
Results of the Randomized Aldosterone Antagonism in Heart Failure With Preserved Ejection Fraction Trial (RAAM-PEF)
Anita Deswal et al.
JOURNAL OF CARDIAC FAILURE (2011)
Determinants of Exercise Intolerance in Elderly Heart Failure Patients With Preserved Ejection Fraction
Mark J. Haykowsky et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2011)
Eplerenone in Patients with Systolic Heart Failure and Mild Symptoms.
Faiez Zannad et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Exercise Training in Older Patients With Heart Failure and Preserved Ejection Fraction A Randomized, Controlled, Single-Blind Trial
Dalane W. Kitzman et al.
CIRCULATION-HEART FAILURE (2010)
Making the Case for Skeletal Myopathy as the Major Limitation of Exercise Capacity in Heart Failure
Holly R. Middlekauff
CIRCULATION-HEART FAILURE (2010)
Randomized Double-Blind Trial of Enalapril in Older Patients With Heart Failure and Preserved Ejection Fraction
Dalane W. Kitzman et al.
CIRCULATION-HEART FAILURE (2010)
Exercise Hemodynamics Enhance Diagnosis of Early Heart Failure With Preserved Ejection Fraction
Barry A. Borlaug et al.
CIRCULATION-HEART FAILURE (2010)
Efficacy of Spironolactone Therapy in Patients With True Resistant Hypertension
Fabio de Souza et al.
HYPERTENSION (2010)
Global Cardiovascular Reserve Dysfunction in Heart Failure With Preserved Ejection Fraction
Barry A. Borlaug et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2010)
Effect of Spironolactone on Left Ventricular Mass and Aortic Stiffness in Early-Stage Chronic Kidney Disease A Randomized Controlled Trial
Nicola C. Edwards et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2009)
Aldosterone and vascular inflammation
Nancy J. Brown
HYPERTENSION (2008)
Trends in prevalence and outcome of heart failure with preserved ejection fraction
Theophilus E. Owan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Spironolactone reduces brachial pulse wave velocity and PIIINP levels in hypertensive diabetic patients
J Davies et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2005)
The effect of alagebrium chloride (ALT-711), a novel glucose cross-link breaker, in the treatment of elderly patients with diastolic heart failure
WC Little et al.
JOURNAL OF CARDIAC FAILURE (2005)
Evaluation of the performance and concordance of clinical questionnaires for the diagnosis of heart failure in primary care
C Fonseca et al.
EUROPEAN JOURNAL OF HEART FAILURE (2004)
Effect of aldosterone antagonism on myocardial dysfunction in hypertensive patients with diastolic heart failure
PM Mottram et al.
CIRCULATION (2004)
Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction
B Pitt et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Arterial and cardiac aging: Major shareholders in cardiovascular disease enterprises Part I: Aging arteries: A set up for vascular disease
EG Lakatta et al.
CIRCULATION (2003)
Pathophysiological characterization of isolated diastolic heart failure in comparison to systolic heart failure
DW Kitzman et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2002)
Improved arterial compliance by a novel advanced glycation end-product crosslink breaker
DA Kass et al.
CIRCULATION (2001)
Cardiac cycle-dependent changes in aortic area and distensibility are reduced in older patients with isolated diastolic heart failure and correlate with exercise intolerance
WG Hundley et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2001)
Effect of spironolactone on plasma brain natriuretic peptide and left ventricular remodeling in patients with congestive heart failure
T Tsutamoto et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2001)
Reduction in sample size for studies of remodeling in heart failure by the use of cardiovascular magnetic resonance
NG Bellenger et al.
JOURNAL OF CARDIOVASCULAR MAGNETIC RESONANCE (2000)